alphaveLASA₹6.82

Lasa Supergenerics Limited

₹ CrorePeersMANGALAM BIOFILCHEM ORTINGLOBE VINEETLAB KREBSBIO ALPA BALPHARMA NATCAPSUQMcap ₹34.2 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	83.8	48.1	38.4	38.4
+ Capital Work-in-Progress	2.5	0.2	0.0	0.0
+ Goodwill	11.7	0.0	0.0	0.0
+ Other Intangibles	14.3	19.9	0.0	0.0
+ Intangibles under Development	—	0.0	16.7	16.7
+ Other Non-current Financial Assets	0.7	0.8	0.8	0.8
Non-current Financial Assets	0.7	0.8	0.8	0.8
Total Non-current Assets	113.0	69.0	55.8	55.8
Current Assets
+ Inventories	19.0	24.5	1.8	1.8
+ Trade Receivables	3.6	1.5	0.0	0.0
+ Cash & Cash Equivalents	0.6	0.3	0.3	0.3
+ Other Bank Balances	0.9	0.5	0.4	0.4
+ Short-term Loans	0.1	0.1	0.1	0.1
+ Other Current Financial Assets	13.7	0.0	—	—
Current Financial Assets	18.8	2.3	0.8	0.8
+ Other Current Assets	—	5.7	7.8	7.8
Total Current Assets	37.9	32.5	10.4	10.4
Total Assets	150.9	101.5	66.3	66.3
Equity
+ Equity Share Capital	50.1	50.1	50.1	50.1
+ Other Equity / Reserves	46.6	33.6	-0.5	-0.5
Equity — Owners of Parent	96.7	83.7	49.6	49.6
Total Equity	96.7	83.7	49.6	49.6
Liabilities
+ Borrowings — Non-current	0.0	0.4	0.0	0.0
Non-current Financial Liabilities	0.0	0.4	0.0	0.0
+ Provisions — Non-current	0.5	0.0	0.2	0.2
+ Deferred Tax Liabilities	4.8	0.2	-0.3	-0.3
Non-current Liabilities	5.3	0.7	-0.1	-0.1
+ Borrowings — Current	22.1	2.1	9.7	9.7
+ Trade Payables	14.1	10.2	2.1	2.1
Current Financial Liabilities	36.1	12.3	11.9	11.9
+ Provisions — Current	11.3	0.0	2.3	2.3
+ Current Tax Liabilities	—	1.5	0.0	0.0
+ Other Current Liabilities	1.5	3.3	2.6	2.6
Current Liabilities	48.9	17.2	16.8	16.8
Total Liabilities	54.2	17.8	16.6	16.6
Total Equity & Liabilities	150.9	101.5	66.3	66.3
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	4.4	0.2	0.2
+ Dues to Other Creditors — Current	—	5.9	1.9	1.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.